Status:
COMPLETED
Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
SARS-CoV-2
Systemic Lupus Erythematosus
Eligibility:
All Genders
18+ years
Brief Summary
This epidemiological, transversal, cohort study aims to determine the potential influence of an active long-term hydroxychloroquine intake over the prevalence of a history of symptoms evocative of a C...
Eligibility Criteria
Inclusion
- History of Systemic Lupus Erythematosus, Rheumatoid arthritis, Sjogren's Syndrome or Psoriatic Arthritis.
Exclusion
- beginning, or end, of an hydroxychloroquine treatment between Jan 1, 2020 and day of the phone call.
- Bad treatment compliance
Key Trial Info
Start Date :
April 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
572 Patients enrolled
Trial Details
Trial ID
NCT04345159
Start Date
April 17 2020
End Date
November 30 2020
Last Update
January 7 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondation Adolphe de Rothschild
Paris, France, 75019